|Podcasts|August 10, 2021

What Can ClinOps Learn from Pre-Clinical?

Author(s)Lisa Henderson, Andy Studna, Senior Editor

Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

Lab orchestration is often reduced to scheduling and automation, but a connected scientific record across the physical, logical, and digital domains is what actually makes AI-ready research possible. Credit: Stock.Adobe.com/VStudio.

Lab Orchestration Is Not What You Think It Is

ByRyan Bernhardt

September 11th 2026

ACT Brief: Patient Voice in Protocol Design, AI-Informed Recruitment Workflows, and Engagement Maturity Beyond Performative

ByAndy Studna, Senior Editor

September 11th 2026

ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization

ByAndy Studna, Senior Editor

September 10th 2026

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable

ByOtis Johnson, PhD, MPA,Joseph Geraci, PhD,Andy Studna, Senior Editor

September 9th 2026

ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis

ByAndy Studna, Senior Editor

September 9th 2026

Trending on Applied Clinical Trials Online

From Participation to Understanding: Reframing Engagement in Clinical Trials

Recruitment in the Age of AI: Q&A with John Worden, Javara

What It Actually Means to Embed the Patient Voice in Trial Design

Lab Orchestration Is Not What You Think It Is

Why Seizure Counts Alone Can't Define Success in Epilepsy Trials